Senate Committee’s PREVENT Pandemics Act Draft Released: What to Know
Healthcare Law Today
FEBRUARY 1, 2022
The pilot program, which will wind down at the end of 2027, first requires the FDA to issue guidance on implementation and to provide regular reporting on projects. Seeks to expedite the development of new manufacturing approaches for novel drug development by creating a pilot program to reduce development time.
98 
Let's personalize your content